Two lines of Friend virus (FV)-transformed mouse spleen cells have been analyzed in respect to their interferon production capacity: neither F4 cells, which liberate infectious FV when kept under tissue culture conditions, nor the thymidine kinase-deficient B8 cells, which do not produce significant amounts of FV, release detectable amounts of autogenous interferon into cell supernatants. However, interferon is produced in these cells in amounts comparable to that in L-929 cells when interferon induction is initiated with UV-inactivated Newcastle disease virus. Conversely poly(I) -poly(C), a potent interferon inducer in L-929 cells, proved ineffective in this capacity in F4 or B8 cells. When erythropoietic differentiation is induced in these cells by dimethyl sulfoxide, no autogenous interferon production occurs, but with NDV-induction a four-to fivefold increase of interferon production is observed. A similar elevation of interferon production is achieved during 5-bromodeoxyuridine stimulation of differentiation in the thymidine kinase-deficient B8 cells. The refractiveness against poly (I) .poly(C) displayed in unstimulated cells is not overcome at any stage of differentiation, indicating major differences of Newcastle disease virus and poly(I) -poly(C) induction mechanisms.
When transformed by Friend virus (FV), mouse spleen lymphocytes can be propagated under tissue culture conditions (9, 21) . A cloned line (F4) of FV-transformed mouse spleen cells produces infectious virus (17) containing both components of the FV complex (8) , the spleen focus-forming virus, and the murine leukemia virus-Friend (7, 20) . Addition of dimethyl sulfoxide (ME2SO) to the culture medium of these transformed cells induces their differentiation along the erythropoietic pathway (9, 17) . The 5-bromo-2'-deoxyuridine (BrdU)-resistant cellline B8 of the same origin likewise can be induced to differentiate by ME2SO but also by high concentrations of BrdU (6, 16) . This BrdUinduced hemoglobin synthesis in B8 cells (but not the ME2SO induced) is accompanied by a transient burst in FV synthesis on the second day of BrdU treatment (18) . Exogenous interferon inhibits this virus induction (Ostertag, Crozier, and Swetly, manuscript in preparation)
as well as the FV release in F4 cells (22) , demonstrating that these FV-transformed cells are sensitive to interferon. The synthesis of hemoglobin which is induced during the erythroid differentiation remains unaffected by the presence of interferon (22) . cells to synthesize and release interferon is 27 investigated by using different inducers, Newcastle disease virus (NDV) or poly(I) -poly(C).
Erythropoietic differentiation, stimulated in F4 cells by addition of ME2SO and in B8 cells by ME2SO or by BrdU, occurs concurrently for more than 70% of the cells (6) and permits for the first time a study of interferon inducibility at the different stages of cellular differentiation.
MATERIALS AND METHODS Cells and viruses. The FV-transformed cloned mouse spleen cell line F4 and the BrdU-resistant mutant B8 have been obtained from W. Ostertag, and their isolation and properties are published (6, 16, 21 Poly(I) *poly(C) has been purchased from Miles Laboratories; DEAE-dextran was from Pharmacia; and neomycin was from C. H. Boehringer, Ingelheim.
Stimulation of erythropoietic differentiation and hemoglobin synthesis. To cells growing at a density of 0.5 x 106 to 106 cells/ml, ME2SO is added on day 1 at a concentration of 1%. Cells are then transferred in daily intervals to fresh medium containing MESO at concentrations: 1.25% on day 2, 1.5% on day 3, and 1.75% on days 4 and 5. The cell density throughout the stimulation period is maintained at 106 to 1.5 x 10. cells/ml. The BrdU stimulation of differentiation in BrdU-resistant B8 cells is carried out in cells which have been maintained for a period of 8 weeks in medium without BrdU. Cells are plated then at a density of 10' cells/ml and exposed to medium with 0.8 mM BrdU with daily changes of medium through a 5-day stimulation period. The percentage of cells involved in erythroid differentiation and synthesizing hemoglobin has been determined by methanol fixation of cells on slides and staining with benzidineWright-Giemsa. A minimum of 103 cells has been scored for the ratio of benzidine reactive cells to viable cells in culture.
Production of interferon in the FV-transformed cells. Production of interferon in F4 and B8 cells has been assayed in supernatants of cultures kept either without MESO or in presence of ME2SO. Medium which has supported cellular growth for at least 24 h has been centrifuged to remove cells (800 x g, 10 min), and cell debris and supernatant virus (82,000 x g, 50 min) were adjusted to pH 2.5 with 1 N HCl and dialyzed against 0.1 M glycin-hydrochloride buffer, pH 2.5, for 5 days at 4 C. After adjustment to neutral pH, the amount of interferon has been determined by its capacity to inhibit the cytopathic effect of vesicular stomatitis virus in L-929 mouse cells. One unit of interferon is defined as the reciprocal of the highest dilution of a sample that reduces vesicular stomatitis virus plaque formation in a L-929 cell culture by 50%. The plaque assay has been standardized with an NIH reference standard mouse interferon preparation.
Induction of interferon production. Two types of interferon-inducing agents have been applied: UVinactivated NDV and poly(I) poly(C) with DEAEdextran and neomycin.
The NDV induction of interferon has been carried out by removing the medium from cells and exposing them to aliquots of 0.6 hemagglutinating units of NDV per 106 cells for 1 h at 37 C, in a volume of 0.5 ml of phosphate-buffered saline. For poly (I) .poly(C) induction of interferon, a spectrum of inducer concentrations ranging from 0.5 to 40 jg of poly(I) -poly(C), 10 to 500 gg of DEAE-dextran, and 300 jg of neomycin in phosphate-buffered saline per 106 cells has been applied. Mouse L-929 cells serve as controls in the interferon induction experiments. In these cells interferon induction is optimal when 106 cells are exposed to 4 jig of poly(I) .poly(C), 100 jig of DEAE-dextran, and 300 jg of neomycin for 30 min at 25 C. For the poly(I) .poly(C) induction, the spleen cells are grown as described above and centrifuged at 1,000 x g for 5 min, and the resulting cell pellets are exposed to various concentrations of poly(I) -poly(C) at 25 C for 30 min. Controls are obtained by incubating cells in phosphate-buffered saline without inducers. After the incubation period the cells are washed four times with medium without serum and further incubated at 37 C in serum-containing medium with the appropriate amounts of MESO or BrdU for interferon induction in differentiating cells. Cell-free supernatants are tested for interferon after 24 h as described above. Cell counts and benzidine staining of cells are carried out to relate interferon production to cell number and to cell differentiation.
Cell numbers are determined by counting the viable cells after trypan blue staining in a hemocytometer.
RESULTS
No autogenous interferon production occurs in FV-transformed cells. Table 1) . Induction of interferon production succeeds with UV-inactivated NDV but not with poly(I) -poly(C). To relate the failure of interferon production in the FV releasing cells, either to a defect caused by the inability of the transformed cells to synthesize interferon or to a defect of FV to induce it, the following experiment has been performed. F4 or B8 cells are exposed to either of two established interferon inducers: UV-inactivated NDV and the doublestranded polynucleotide poly(I).poly(C). This second inducer is ineffective by itself in another mouse cell line (L-929); however, in the presence of DEAE-dextran (5) and neomycin (2), it induces interferon production in L-929 cells to a level of 5,000 U/106 cells. A cell toxic effect is associated with this interferon induction. The results are summarized in Table 1 and represent data from five experiments. For induction of interferon in F4 and B8 cells, the concentration of poly(I) -poly(C) has been varied between 0.5 and 40 ,ug per 106 cells. Neither of the applied concentrations, without or in combination with various amounts of DEAE-dextran and with neomycin, have resulted in an induction of interferon or in significant cell toxicity. In contrast to this inability of poly(I) poly(C) to induce interferon in the FV-transformed spleen cells, UV-inactivated NDV induces about 5,000 U of interferon/106 cells. No significant difference in the interferon production has been found between the FV releasing F4 cells and the B8 cells, which do not produce virus.
The amount of interferon induced by NDV depends on the stage of erythropoietic cell differentiation. Not only hemoglobin synthesis increases but also the release of FV from F4 cells goes up more than 10-fold when ME2SO is added and cells begin to differentiate (22) . However, when F4 cells are exposed to 2 x 10-5 M BrdU for 2 days before and then during the 5 days of ME2SO treatment, no significant effect on cell growth and viability occurs, but hemoglobin synthesis is inhibited (16) . Interferon may be seen also as a specialized cellular product, and thus it appeared interesting to follow the capacity of the cell to respond to NDV induction of interferon at different stages of the erythropoietic differentiation.
The F4 cells have been treated either with 2 x 10-5 M BrdU for 2 days and then exposed to ME2SO and BrdU, or without pretreatment exposed to ME2SO. In daily intervals, UVirradiated NDV was added to aliquots of 2 x 107 cells, incubation was carried on for 24 h in ME2SO-containing medium with or without BrdU, and cell virus-free supernatants were assayed for interferon. The percentage of cells involved in erythroid differentiation is determined by benzidine staining. The results are presented in Fig. 1 . Interferon production increases fourfold on day 3 of the stimulation period. This time coincides with a strong increase in hemoglobin synthesis in these cells. During the late phase of stimulation, the interferon production decreases again to a level below that of unstimulated cells. The optimum of interferon production fluctuated slightly between days 2 and 3. Treatment of cells with BrdU, which inhibits the hemoglobin synthesis (Fig. 1, lower panel) , keeps the NDV-induced interferon production on the level of un-tion of more than 60% of the cells in culture and to patterns of interferon synthesis similar to 20 that in ME2SO-treated F4 cells (Fig. 2A) . Interferon production rises to 16 (Fig. 2b) To distinguish between the two possibilities, ME2SO stimulation of hemoglobin synthesis has been inhibited in BrdU-sensitive F4 cells by a low dose of BrdU, which does not affect cell proliferation (16) . Under these condition the increase in interferon induction is not observed, which indicates that the mere presence of ME2SO does not facilitate interferon induction but that cells had to evolve in their differentiation.
In BrdU-resistant B8 cells hemoglobin production can be induced by high concentrations of BrdU also in the absence of ME2SO. The two-to threefold increase of interferon inducibility when cells had been stimulated for 3 A special property of these transformed spleen cells seems to be the refractiveness of interferon production mechanism to poly(I). poly(C) induction. A wide variety of reaction conditions as well as the presence of DEAE-dextran and/or neomycin did not lead to measurable interferon induction.
When differentiating cells are challenged with poly(I) -poly(C) under similar conditions where NDV-mediated induction is elevated, no release of interferon is observed. That these cells remain refractive to the polynucleotide inducer may reflect either a property of the cell membrane (nucleolytic activity) or a fundamental difference in the induction mechanisms by NDV and poly(I) -poly(C) (3), the latter being inactive here.
